| Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 SKSS Pindiprolu, SH Pindiprolu Medical hypotheses 140, 109765, 2020 | 70 | 2020 |
| Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles S Tummala, MNS Kumar, SK Pindiprolu Drug delivery 23 (9), 3505-3519, 2016 | 65 | 2016 |
| RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies VT Siddhartha, SKSS Pindiprolu, PK Chintamaneni, S Tummala, ... Artificial cells, nanomedicine, and biotechnology 46 (2), 387-397, 2018 | 56 | 2018 |
| Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells SKSS Pindiprolu, PK Chintamaneni, PT Krishnamurthy, ... Drug development and industrial pharmacy 45 (2), 304-313, 2019 | 47 | 2019 |
| Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent SKSS Pindiprolu, CSP Kumar, VSK Golla, P Likitha, S Chandra, EB SK, ... Medical hypotheses 143, 109858, 2020 | 40 | 2020 |
| Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles SV Talluri, G Kuppusamy, VVSR Karri, K Yamjala, A Wadhwani, ... Artificial cells, nanomedicine, and biotechnology 45 (3), 474-488, 2017 | 39 | 2017 |
| Nanocarrier based approaches for targeting breast cancer stem cells SKSS Pindiprolu, PT Krishnamurthy, PK Chintamaneni, VVSR Karri Artificial cells, nanomedicine, and biotechnology 46 (5), 885-898, 2018 | 31 | 2018 |
| Pharmacological targets of breast cancer stem cells: a review SKSS Pindiprolu, PT Krishnamurthy, PK Chintamaneni Naunyn-Schmiedeberg's archives of pharmacology 391, 463-479, 2018 | 26 | 2018 |
| Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria L Gujjari, H Kalani, SK Pindiprolu, BP Arakareddy, G Yadagiri Parasite Epidemiology and Control 17, e00244, 2022 | 25 | 2022 |
| Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer SK SS Pindiprolu, PT Krishnamurthy, VR Ghanta, PK Chintamaneni Nanomedicine 15 (16), 1551-1565, 2020 | 22 | 2020 |
| Type-II endometrial cancer: Role of adipokines KK Garikapati, VVVRK Ammu, PT Krishnamurthy, PK Chintamaneni, ... Archives of gynecology and obstetrics 300, 239-249, 2019 | 20 | 2019 |
| DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer SKSS Pindiprolu, PT Krishnamurthy, C Dev, PK Chintamaneni Chemistry and Physics of Lipids 235, 105033, 2021 | 19 | 2021 |
| Possible role of PPAR-γ and COX-2 receptor modulators in the treatment of Non-Small Cell lung carcinoma VVVRK Ammu, KK Garikapati, PT Krishnamurthy, PK Chintamaneni, ... Medical hypotheses 124, 98-100, 2019 | 19 | 2019 |
| Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer’s disease PK Chintamaneni, PT Krishnamurthy, PV Rao, SKSS Pindiprolu Medical hypotheses 101, 17-22, 2017 | 19 | 2017 |
| Optical emissions of chitosan modified LaAlO3: Bi3+, Tb3+ nanoparticles for bio labeling and drug delivery to breast cancer cells EB Shaik, SKSS Pindiprolu, CS Phanikumar, T Samuel, BVN Kumar, ... Optical Materials 107, 110162, 2020 | 16 | 2020 |
| HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer MK Singh, SKSS Pindiprolu, BKR Sanapalli, V Yele, GNK Ganesh International journal of biological macromolecules 150, 631-636, 2020 | 16 | 2020 |
| CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma SH Pindiprolu, SKSS Pindiprolu Medical Hypotheses 129, 109241, 2019 | 16 | 2019 |
| Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: In vitro studies MK Singh, SKSS Pindiprolu, BKR Sanapalli, V Yele, GNK Ganesh RSC advances 9 (43), 24987-24994, 2019 | 16 | 2019 |
| New 1, 2, 4‐Triazole Scaffolds as Anticancer Agents: Synthesis, Biological Evaluation and Docking Studies NK Maddali, VKV Ivaturi, LN Murthy Yellajyosula, V Malkhed, ... ChemistrySelect 6 (26), 6788-6796, 2021 | 15 | 2021 |
| Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer’s disease NSS Chalichem, PSS Sai Kiran, D Basavan Journal of Drug Targeting 26 (8), 670-675, 2018 | 14 | 2018 |
Pavan kumar ChintamaneniAsst Professor, Dept. of Pharmaceutics GITAM School of Pharmacy, GITAM Deemed to be University-Hyd在 gitam.edu 的电子邮件经过验证
